158 related articles for article (PubMed ID: 38454241)
21. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
22. A 7-gene signature predicts the prognosis of patients with bladder cancer.
Tang F; Li Z; Lai Y; Lu Z; Lei H; He C; He Z
BMC Urol; 2022 Jan; 22(1):8. PubMed ID: 35090432
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
24. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
Yang W; An L; Li Y; Qian S
Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206
[TBL] [Abstract][Full Text] [Related]
25. Identification of a chemotherapy-associated gene signature for a risk model of prognosis in gastric adenocarcinoma through bioinformatics analysis.
Shen Y; Chen K; Gu C
J Gastrointest Oncol; 2022 Oct; 13(5):2219-2233. PubMed ID: 36388651
[TBL] [Abstract][Full Text] [Related]
26. A signature of 24 aging‑related gene pairs predict overall survival in gastric cancer.
Zhang Y; Yan Y; Ning N; Shen Z; Ye Y
Biomed Eng Online; 2021 Apr; 20(1):35. PubMed ID: 33823856
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
28. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
30. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
31. Identification of metabolism-related gene signature in lung adenocarcinoma.
Wang N; Wang H
Medicine (Baltimore); 2023 Nov; 102(47):e36267. PubMed ID: 38013279
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a 10-gene prognostic model for gastric cancer based on the tumor immune microenvironment.
Yu J; Li T; Han H; Zeng F; Wu Z; Zhang J; Chen Y; Sheng B; Deng S; Zhu P
Anal Biochem; 2022 Oct; 654():114794. PubMed ID: 35777456
[TBL] [Abstract][Full Text] [Related]
33. A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies.
Ji D; Yang Y; Zhou F; Li C
Front Genet; 2022; 13():909175. PubMed ID: 36226177
[No Abstract] [Full Text] [Related]
34. Drug metabolism-related eight-gene signature can predict the prognosis of gastric adenocarcinoma.
Yin HM; He Q; Chen J; Li Z; Yang W; Hu X
J Clin Lab Anal; 2021 Dec; 35(12):e24085. PubMed ID: 34773716
[TBL] [Abstract][Full Text] [Related]
35. Identification of a prognostic 5-Gene expression signature for gastric cancer.
Hou JY; Wang YG; Ma SJ; Yang BY; Li QP
J Cancer Res Clin Oncol; 2017 Apr; 143(4):619-629. PubMed ID: 28035468
[TBL] [Abstract][Full Text] [Related]
36. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
Li F; Niu Y; Zhao W; Yan C; Qi Y
Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
[TBL] [Abstract][Full Text] [Related]
37. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
[No Abstract] [Full Text] [Related]
38. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
39. A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer.
Cao P; Chen M; Zhang T; Zheng Q; Liu M
Eur J Med Res; 2023 Nov; 28(1):515. PubMed ID: 37968767
[TBL] [Abstract][Full Text] [Related]
40. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
